Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Journal of Experimental Hematology ; (6): 445-448, 2007.
Article Dans Chinois | WPRIM | ID: wpr-230248

Résumé

Tumor angiogenesis is a complicated process in which VEGF and the members of Ang family have been proposed to play an important role. Ang family is the only vascular growth factor family including activators and inhibitors. They can all bind with specific tyrosine kinase receptor Tie-2 and participate in angiogenesis. Vascular endothelial growth factor (VEGF) is secreted by tumor cells and coordinates with Ang to promote angiogenesis. Further research on the structure and functional mechanism of VEGF and Ang will contribute to develop a new type of antiangiogenesis medicine, which might have good perspect in clinical practice. In this paper, the structure and action mechanism of Ang family and its receptor Tie-2, the application of Ang family and Tie in tumor therapy, and the synergic mechanism between Ang and VEGF were summarized.


Sujets)
Animaux , Humains , Inhibiteurs de l'angiogenèse , Pharmacologie , Angiopoïétine-2 , Pharmacologie , Synergie des médicaments , Tumeurs , Néovascularisation pathologique , Facteurs de croissance endothéliale vasculaire , Pharmacologie
SÉLECTION CITATIONS
Détails de la recherche